We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$23.5B
AUM Growth
-$574M
Cap. Flow
-$385M
Cap. Flow %
-1.64%
Top 10 Hldgs %
23.48%
Holding
1,876
New
481
Increased
362
Reduced
407
Closed
492

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$232M
2
CSCO icon
Cisco
CSCO
+$212M
3
PFE icon
Pfizer
PFE
+$187M
4
LW icon
Lamb Weston
LW
+$172M
5
CMCSA icon
Comcast
CMCSA
+$156M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$286M
2
META icon
Meta Platforms (Facebook)
META
+$165M
3
ELV icon
Elevance Health
ELV
+$160M
4
CRM icon
Salesforce
CRM
+$160M
5
TJX icon
TJX Companies
TJX
+$147M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 20.96%
3 Communication Services 13.02%
4 Consumer Discretionary 11.83%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
1401
Arthur J. Gallagher & Co
AJG
$68.6B
-103,457
Closed -$14.5M
AKAM icon
1402
Akamai
AKAM
$15.4B
-9,878
Closed -$1.15M
AKR icon
1403
Acadia Realty Trust
AKR
$2.85B
-20,292
Closed -$446K
ALK icon
1404
Alaska Air
ALK
$4.72B
-132,928
Closed -$8.02M
ALL icon
1405
Allstate
ALL
$65.9B
-126,551
Closed -$16.5M
ALLO icon
1406
Allogene Therapeutics
ALLO
$698M
-325,040
Closed -$8.48M
ALNY icon
1407
Alnylam Pharmaceuticals
ALNY
$31.7B
-108,585
Closed -$18.4M
ALXO icon
1408
ALX Oncology
ALXO
$277M
-19,093
Closed -$1.04M
AMAT icon
1409
Applied Materials
AMAT
$366B
-161,782
Closed -$23M
AMCR icon
1410
Amcor
AMCR
$21.6B
-9,290
Closed -$532K
AMED
1411
DELISTED
Amedisys
AMED
-213,359
Closed -$52.3M
AMGN icon
1412
Amgen
AMGN
$234B
-63,921
Closed -$15.6M
AMRC icon
1413
Ameresco
AMRC
$1.17B
-90,031
Closed -$5.65M
ANF icon
1414
Abercrombie & Fitch
ANF
$6.59B
-28,895
Closed -$1.34M
AOSL icon
1415
Alpha and Omega Semiconductor
AOSL
$745M
-40,785
Closed -$1.24M
APH icon
1416
Amphenol
APH
$194B
-18,446
Closed -$631K
APLS
1417
DELISTED
Apellis Pharmaceuticals
APLS
-3,809
Closed -$241K
ARMK icon
1418
Aramark
ARMK
$15.3B
-24,803
Closed -$667K
ARVN icon
1419
Arvinas
ARVN
$600M
-449,285
Closed -$34.6M
ARWR icon
1420
Arrowhead Research
ARWR
$12B
-2,710
Closed -$224K
ASIX icon
1421
AdvanSix
ASIX
$445M
-18,914
Closed -$565K
ATEX icon
1422
Anterix
ATEX
$1.81B
-4,030
Closed -$243K
AVAV icon
1423
AeroVironment
AVAV
$7.52B
-86,388
Closed -$8.65M
AXTA icon
1424
Axalta
AXTA
$7.92B
-1,176,382
Closed -$35.9M
AYI icon
1425
Acuity Brands
AYI
$10B
-14,018
Closed -$2.62M

Similar funds

Marshall Wace North America's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace North America held 1,876 positions worth $23.5B, down 2.4% from $24.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace North America's Q3 2021 filing shows 481 new, 362 increased, 407 reduced and 492 closed positions. Its largest new stake was Cisco: 3,779,633 shares worth $206M. The largest sale was Danaher, an estimated $286M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Marshall Wace North America's largest Q3 2021 buy was Cisco: 3,779,633 shares worth $206M.
  • Marshall Wace North America added most to Uber in Q3 2021, an estimated $232M increase.
  • Marshall Wace North America's biggest Q3 2021 reduction was Danaher, cutting an estimated $286M.
  • Marshall Wace North America fully exited CIMAREX ENERGY CO in Q3 2021, selling an estimated $81.7M.
  • Marshall Wace North America's ten largest holdings make up 23% of its $23.5B portfolio in Q3 2021.
  • Marshall Wace North America opened 481 new positions and closed 492 in Q3 2021.
  • Marshall Wace North America's portfolio value fell 2.4% quarter-over-quarter to $23.5B.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.